You just read:

NICE Recommends Genomic Health's Oncotype DX® Test To Guide Chemotherapy Treatment Decisions For Qualified Early-Stage Invasive Breast Cancer Patients

News provided by

Genomic Health, Inc.

Sep 25, 2013, 05:30 ET